PubRank

B P Hamilton

Author PubWeight™ 39.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group. JAMA 1996 2.94
2 Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 1992 1.89
3 Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J Hypertens 1996 1.83
4 A circulating inhibitor of (Na+ + K+)ATPase associated with essential hypertension. Nature 1982 1.59
5 Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Arch Intern Med 1998 1.49
6 Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens 1994 1.19
7 A comparative study of urinary 17-hydroxycorticosteroids, urinary free cortisol, and the integrated concentration of plasma cortisol. J Clin Endocrinol Metab 1980 1.17
8 The short cardiac pre-ejection period: an index to thyrotoxicosis. Circulation 1974 1.16
9 Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertens Res 2000 1.06
10 Ouabain is secreted by bovine adrenocortical cells. Endocrinology 1994 1.05
11 Age-related probability of development of hereditary medullary thyroid carcinoma. J Pediatr 1982 0.98
12 Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat. Hypertens Res 2000 0.95
13 Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 1997 0.95
14 Systolic time intervals in hypothyroidism: end organ function as a reflection of clinical status. Am J Med Sci 1979 0.94
15 Secretion of endogenous ouabain from bovine adrenocortical cells: role of the zona glomerulosa and zona fasciculata. Biochem Biophys Res Commun 1995 0.90
16 Structure-activity relationships for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring. Hypertension 2001 0.88
17 Pseudohyperparathyroidism in head and neck tumors. Cancer 1974 0.88
18 Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial. J Am Coll Cardiol 1994 0.85
19 Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain. Clin Exp Hypertens 1998 0.84
20 Different signaling pathways mediate stimulated secretions of endogenous ouabain and aldosterone from bovine adrenocortical cells. Hypertension 1998 0.84
21 Improvement in depressed cardiac function in hypertensive patients during pindolol treatment. Am J Med 1984 0.82
22 The effect of prostaglandin inhibition on renin release. A comparison of furosemide and low-sodium stimulation tests. J Lab Clin Med 1981 0.81
23 Cardiac arrhythmias after abrupt clonidine withdrawal. Clin Pharmacol Ther 1983 0.81
24 The Veterans Affairs Implantable Insulin Pump Study: effect on cardiovascular risk factors. Diabetes Care 1998 0.81
25 Incidence of cardiac arrhythmias associated with mild hypokalemia induced by low-dose diuretic therapy for hypertension. South Med J 1989 0.80
26 Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia type II. Am J Med 1978 0.80
27 Attempted treatment of inoperable pheochromocytoma with streptozocin. Arch Intern Med 1977 0.80
28 Effects of angiotensin II on sodium potassium pumps, endogenous ouabain, and aldosterone in bovine zona glomerulosa cells. Hypertension 1999 0.80
29 Evidence for the presence of neurophysin in tumors producing the syndrome of inappropriate antidiuresis. J Clin Endocrinol Metab 1972 0.79
30 Treatment of essential hypertension with PN 200-110 (isradipine). Am J Cardiol 1987 0.79
31 Isotope effects in the metabolism of labeled steroids. J Steroid Biochem 1979 0.79
32 Intrinsic sympathomimetic activity of pindolol. Evidence for interaction with pretreatment sympathetic tone. Am J Med 1983 0.79
33 Adrenal vein epinephrine levels: a useful aid in venous sampling for primary aldosteronism. Ann Intern Med 1982 0.79
34 Plasma norepinephrine and epinephrine responses to glucagon in patients with suspected pheochromocytomas. Metabolism 1983 0.78
35 Thyroid hormone levels after acute L-thyroxine loading in hypothyroidism. J Clin Endocrinol Metab 1981 0.78
36 Effect of adrenal suppression with dexamethasone in essential hypertension. J Clin Endocrinol Metab 1979 0.77
37 Red cell cotransport activity and sodium content in black men. Relationship to essential hypertension. Hypertension 1984 0.77
38 Pindolol in the treatment of hypertension: systolic time intervals as a predictor of response to beta receptor blockade. Am J Cardiol 1980 0.76
39 Symptomatic Rathke's cleft cyst with amyloid stroma. J Neurol Neurosurg Psychiatry 1975 0.75
40 Relationships among endogenous digitalis-like factors in essential hypertension. Fed Proc 1985 0.75
41 Effect of the administration of zinc sulfate on hypogonadism and impotence in patients with chronic stable hepatic cirrhosis. J Am Coll Nutr 1983 0.75
42 Regioselective derivatization of ouabain with trialkylsilyl reagents and selective oxidation of the unprotected alcohols. Steroids 2000 0.75
43 Catecholamine suppression testing in patient with phaechromocytoma and normal plasma catecholamine levels. Lancet 1983 0.75
44 Pindolol and systolic time intervals in patients with hypertension. Am Heart J 1982 0.75
45 Red blood cell Na+,K+-ATPase in men with newly diagnosed or previously treated essential hypertension. Hypertension 1987 0.75
46 Integrated concentration of epinephrine and norepinephrine in normal subjects and in patients with mild essential hypertension. J Clin Endocrinol Metab 1980 0.75
47 Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators. Am J Hypertens 2000 0.75
48 Serum thyroid hormone changes during whole body hyperthermia. Cancer 1984 0.75
49 Presence of neurophysin proteins in tumors associated with the syndrome of inappropriate ADH secretion. Ann N Y Acad Sci 1975 0.75
50 The integrated concentration of plasma renin activity and aldosterone in essential hypertension. Johns Hopkins Med J 1978 0.75
51 Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine. Clin Pharmacol Ther 1984 0.75
52 One year experience of elderly hypertensive patients with isradipine therapy. J Hum Hypertens 1994 0.75
53 A comparison of the safety of therapeutically equivalent doses of isradipine and diltiazem for treatment of essential hypertension. Am J Hypertens 1992 0.75
54 Pulmonary function in hypertensive patients treated with pindolol: a report of two studies. Am Heart J 1982 0.75
55 Studies using releasing factors in Klinefelter's syndrome: the responses of LH and FSH to luteinizing hormone-releasing hormone and of prolactin and TSH to thyrotropin-releasing hormone before and after testosterone. Psychoneuroendocrinology 1981 0.75
56 Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio. Hypertension 1986 0.75